Novartis Oncology Budget Analyst Salary | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Budget Analyst Salary

The average Novartis Oncology Budget Analyst earns an estimated $83,046 annually. Novartis Oncology's Budget Analyst compensation is $15,121 more than the US average for a Budget Analyst.

The Finance Department at Novartis Oncology earns $23,951 more on average than the Admin Department.

Last updated 3 years ago.

$35k
$45k
$53k
$62k
$96k
$135k
$158k
$83,046
Average Compensation
$83,046
avg. base

Budget Analyst Salaries at Novartis Oncology

Budget Analysts earn $13,869 more than Accountants, and $6,520 less than Senior Accountants.

Accounting Manager
$105k*
Business Analyst
$92k*
Financial Analyst
$92k*
Senior Accountant
$90k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

The Finance Department averages $23,951 more than the Admin Department, and $6,796 less than the Operations Department

Operations
$90,563 Avg. total comp.
+$7k
Finance
$83,767 Avg. total comp.
Admin
$59,816 Avg. total comp.
-$24k

Budget Analyst Compensation by Gender (All Companies)

The average female Budget Analyst at companies similar size to Novartis Oncology reported making $98,833, while the average male Budget Analyst at similar sized companies reported making $76,324.

Budget Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Budget Analyst at companies similar size to Novartis Oncology reported making $101,500, while the average African American/Black Budget Analyst at similar sized companies reported making $70,000.

How Budget Analysts at Novartis Oncology Rate Their Compensation

The majority of Budget Analysts at Novartis Oncology believe they're not compensated fairly. 100% of Budget Analysts at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company